Covered recipient · General Payments record
STEVEN ZELENKOFSKE
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2023–2024
$60,000.00
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $48,000.00 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Insmed, Inc. | $43,000.00 | 10 |
| VERTEX PHARMACEUTICALS INCORPORATED | $5,000.00 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Insmed, Inc. | $3,000.00 | 01/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089566423 | CMS |
| Insmed, Inc. | $5,000.00 | 02/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089566405 | CMS |
| Insmed, Inc. | $4,500.00 | 03/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089566425 | CMS |
| Insmed, Inc. | $3,500.00 | 04/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089566409 | CMS |
| Insmed, Inc. | $3,000.00 | 05/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089566407 | CMS |
| Insmed, Inc. | $6,000.00 | 06/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089566413 | CMS |
| Insmed, Inc. | $8,000.00 | 07/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089566417 | CMS |
| Insmed, Inc. | $4,000.00 | 08/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089566415 | CMS |
| Insmed, Inc. | $3,000.00 | 09/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089566419 | CMS |
| Insmed, Inc. | $3,000.00 | 10/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1089566421 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $2,750.00 | 06/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105918470 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $2,250.00 | 11/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105912302 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.